Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-18

Clinical Trial Update: Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo [Phase 4]

View source ↗

Summary

Phase 4 trial conducted in South Kivu, DR Congo evaluates the efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated malaria and has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASAQ (artesunate-amodiaquine) (artesunate-amodiaquine)
  • Coartem (artemether-lumefantrine) (artemether-lumefantrine)

Snippet

Sponsor: Medecins Sans Frontieres, Netherlands | Conditions: Malaria | Phase 4 | Status: COMPLETED